Cargando…
60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development
Cimicifuga racemosa (CR) extracts are important worldwide as therapy for menopausal symptoms. The first medicinal product from CR has been available since 1956 (Germany, Remifemin® [Schaper & Brümmer, Salzgitter, Germany], isopropanolic extract iCR). This review describes how CR developed, via c...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409920/ https://www.ncbi.nlm.nih.gov/pubmed/28155126 http://dx.doi.org/10.1007/s10354-016-0537-z |